Heart Test Laboratories Stock (NASDAQ:HSCS)

Forecast Revenue Ownership Financials Chart

Previous Close

$2.73

52W Range

$2.36 - $29.00

50D Avg

$3.39

200D Avg

$6.62

Market Cap

$2.41M

Avg Vol (3M)

$368.31K

Beta

3.29

Div Yield

-

HSCS Company Profile

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

15

IPO Date

Jun 16, 2022

Website

HSCS Performance

HSCS Financial Summary

	Apr 24	Apr 23	Apr 22
Revenue	$18.60M	$5.15K	$14.37K
Operating Income	$-6.31B	$-6.11M	$-4.71M
Net Income	$-6.61B	$-490.85M	$-4.58M
EBITDA	$-6.31B	$-6.08M	$-4.68M
Basic EPS	$-18.74	$-61.74	$-0.02
Diluted EPS	$-18.74	$-61.74	$-0.02

Fiscal year ends in Apr 24 | Currency in USD

Peer Comparison

Ticker	Company
NURO	NeuroMetrix, Inc.
INVO	INVO Bioscience, Inc.
TIVC	Tivic Health Systems, Inc.
NUWE	Nuwellis, Inc.
BVS	Bioventus Inc.
IINN	Inspira Technologies Oxy B.H.N. Ltd.
OPGN	OpGen, Inc.
RSLS	ReShape Lifesciences Inc.
BBLG	Bone Biologics Corporation
BJDX	Bluejay Diagnostics, Inc.
MOTS	Motus GI Holdings, Inc.
TNON	Tenon Medical, Inc.